EAS updates Lp(a) Consensus Statement
August 30, 2022
The European Atherosclerosis Society (EAS) has published a new consensus statement on lipoprotein(a)1 which recognises the substantial body of evidence from genetic, epidemiological and Mendelian randomisation studies that has been built up since the first consensus paper was published.2 The risk for myocardial infarction (MI) increases at Lp(a) levels above the 75th percentile, whereas higher […]
